Pharmacy Technician Pulse

Personalized Care, Collaboration Key to Navigating Ethics in Oncology Pharmacy

Drug Topics

APRIL 22, 2024

Karen Fancher, PharmD, addresses how hearing the perspectives of colleagues can offer invaluable support to shape individualized approaches to ethical dilemmas in oncology pharmacy.

Empowering Oncology Pharmacists: Driving Innovation and Advancement Through Pharmacist-Led Research

Pharmacy Times

APRIL 15, 2024

The impact pharmacist-led research on oncology pharmacy practice in the field of oncology is undeniable.

Navigating the Landscape of Cannabis Use in Oncology

Pharmacy Times

APRIL 5, 2024

Despite being a Schedule I drug, cannabis is increasingly used in oncology for symptom management, although data remains limited.

Navigating the Oncology Specialty Patient Journey

Drug Topics

DECEMBER 4, 2023

In this conversation from HAS 2023, Randy Falkenrath demystifies the oncology medication management model and explains how specialty pharmacist can help patients access care.

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight.

FDA

Teva enters into oncology biosimilar licensing agreement

European Pharmaceutical Review

APRIL 16, 2024

A new global licensing agreement is set to advance development of an oncology biosimilar candidate. and Spain-based biopharmaceutical company mAbxience, have entered into a strategic deal for a drug candidate that is in development for treating multiple indications in the oncology space.

A Call to Pharmacists in the Delivery of Oncology Care

Pharmacy Times

APRIL 4, 2024

The expanded role of oncology pharmacists includes the opportunity to work in ambulatory settings, infusion centers, delivery of specialized in pharmacy services, evaluation of investigational new drugs, and manager roles in drug chain supply and in coordination of care.

What Does an Oncology Pharmacy Technician Do?

Drug Topics

APRIL 20, 2023

From compounding to cleaning, oncology pharmacy technicians take on key responsibilities in infusion centers.

Compounding

Enhancing Patient-Centric Oncology Care: The Crucial Role of Oncology Pharmacists in Treatment Decision-Making

Pharmacy Times

DECEMBER 1, 2023

Marlo Blazer, PharmD, BCOP, discusses the collaborative nature of the pharmacist's role within the oncology care team.

Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

Pharmacy Times

MARCH 26, 2024

The podcast discusses how City of Hope Chicago fully integrates oncology pharmacists into care teams by positioning them in clinics, improving communication and collaboration to minimize delays for patients and enhance care delivery.

Communication

STAT+: Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO

STAT

MARCH 20, 2024

Robert Ross had thought he would take more time off after his previous company, Surface Oncology, was acquired in September. The immuno-oncology firm had just managed to weather the stormy public markets, which had battered its valuation.

The Role of Oncology Pharmacists Is Evolving in Early-Stage Breast Cancer Treatment Optimization

Pharmacy Times

APRIL 11, 2024

Danielle Roman, PharmD, BCOP, discusses how the role of the oncology pharmacist has changed in recent years in optimizing early-stage breast cancer treatment with targeted therapies.

CG Oncology is first biotech IPO of 2024, raising $380m

pharmaphorum

JANUARY 24, 2024

CG Oncology completes the first biotech IPO of 2024, raising $380 million for its oncolytic virus bladder cancer immunotherapy.

Pharmacy Focus: Oncology Edition - A Look Into Psychedelic Medicines for Oncology Care

Pharmacy Times

JUNE 26, 2023

This month, we have a special crossover episode between Pharmacy Focus: Oncology Edition and the Psychedelic Pharmacy podcast.

Pharmacy Practice in Focus: Oncology Launches Peer-Review Process

Pharmacy Times

FEBRUARY 9, 2024

"Pharmacy Practice in Focus: Oncology" welcomes the launch of the peer-review process.

Why Oncology Pharmacists Should Be at the Helm of Precision Medicine in Oncology

Pharmacy Times

JUNE 30, 2022

Andre Harvin, PharmD, MS, executive director of Pharmacy, Oncology Services at Cone Health, discusses the importance of putting precision medicine programs into oncology practices with pharmacists leading the way.

GSK immuno-oncology treatment achieves novel EU approval

European Pharmaceutical Review

DECEMBER 11, 2023

The European Commission (EC) has approved the first frontline immuno-oncology treatment in the EU for mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer. The post GSK immuno-oncology treatment achieves novel EU approval appeared first on European Pharmaceutical Review.

Chemotherapy

Elements in precision oncology

pharmaphorum

OCTOBER 18, 2023

Elements in precision oncology Mike.Hammerton Wed, 18/10/2023 - 11:15 Bookmark this

Some States Allowing Donation and Redistribution of Oncology Drugs

Drug Topics

FEBRUARY 16, 2023

Collections of oncology drugs in 13 states are being redistributed to patients in need.

Bladder cancer-focused CG Oncology files for IPO

Pharmaceutical Technology

JANUARY 22, 2024

On 18 January 2024, US-based biotech CG Oncology announced it was looking to raise $200m in an upcoming initial public offering (IPO), which will be the first for the biotech sector in 2024.

Thyme Care unveils oncology practice partner network to scale value-based care

Fierce Healthcare

MARCH 15, 2024

Thyme Care, a value-based care enabler focused on oncology, has formally launched a dedicated platform for oncology practice partners. | Thyme Care Oncology Partners spans more than 400 oncologists across 25 states.

Merck, Johnson & Johnson Announce Acquisitions to Bolster Respective Oncology Pipelines

PharmExec

JANUARY 9, 2024

Merck has acquired Harpoon Therapeutics with its clinical stage T-cell engager, whereas Johnson & Johnson acquired Ambrx Biopharma with its expertise in next generation antibody drug conjugates and targeted oncologic therapies.

Approaching Ethical Dilemmas in Oncology Pharmacy

Pharmacy Times

APRIL 10, 2024

Karen Fancher, PharmD, BCOP, discusses some guiding principles for oncology pharmacists when facing ethical dilemmas and provides some recommendations for navigating those challenges.

Expert: Mentorship in Oncology Pharmacy Has an Impact

Pharmacy Times

OCTOBER 12, 2023

The president of HOPA discusses the importance of mentorship in oncology pharmacy as well as the value of HOPA’s mentorship initiatives.

Collaboration to develop novel AI-designed oncology therapy

European Pharmaceutical Review

JANUARY 5, 2024

This treatment has potential for hormone sensitive cancers such as breast cancer, and other oncology indications. The post Collaboration to develop novel AI-designed oncology therapy appeared first on European Pharmaceutical Review. Under a new licensing agreement, Stemline Therapeutics, Inc.,

AbbVie agrees $10 billion oncology acquisition

European Pharmaceutical Review

DECEMBER 1, 2023

Richard Gonzalez, Chairman and Chief Executive Officer for AbbVie stated that the acquisition of ImmunoGen enables the company to further diversify its oncology pipeline across solid tumours and haematologic malignancies. The post AbbVie agrees $10 billion oncology acquisition appeared first on European Pharmaceutical Review.

FDA

Oncology Pharmacists “Approve Every Regimen That Gets Built Into the Oncology EMR,” yet Pharma Often Overlooks Their Role

Pharmacy Times

OCTOBER 24, 2023

Oncology leaders and pharma representatives discuss collaboration best practices.

CG Oncology lines up $180m IPO and a $1bn valuation

pharmaphorum

JANUARY 19, 2024

CG Oncology joins the queue of US biotech companies hoping to complete an IPO, aiming to raise $181m for its late-stage bladder cancer therapy.

Labcorp Announces Expansions to Oncology Portfolio

PharmExec

APRIL 9, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says

Fierce Pharma

JUNE 12, 2023

Bayer recently laid out its ambition | Bayer recently laid out its ambition to achieve $10 billion in sales from its oncology business by 2030 and become a top 10 cancer drug player. To get there, the company is looking outside for a “midsize acquisition,” Bayer’s oncology chief Christine Roth said.

Inflation Reduction Act Could Cause Delay in New Oncology Treatments Under Medicare Negotiations

Pharmacy Times

NOVEMBER 3, 2023

In an article by The New England Journal of Medicine, the authors discuss how drug companies could delay the approval of new oncology drugs under the IRA, delaying patient care.

Patient Care

Cardiff Oncology doses first patient in colorectal cancer trial

Pharmafile

MARCH 1, 2024

Cardiff Oncology has announced that it has dosed the first patient in its randomised first-line phase 2 trial, CRDF-004, for patients with RAS-mutated metastatic colorectal cancer (mCRC).

Dosage

Pharmacy Focus: Student Edition - Oncology Drug Development

Pharmacy Times

APRIL 10, 2023

Brianna Hawkins, MBA, a University of Tennessee Health Science Center doctor of pharmacy candidate, discusses oncology drug development and how students can start a career in this alternative path.

Biofidelity’s ASPYRE: The future is bright for oncology

pharmaphorum

DECEMBER 7, 2023

Biofidelity’s ASPYRE: The future is bright for oncology Mike.Hammerton Thu, 07/12/2023 - 15:58 Bookmark this

Antibody-drug conjugates: paving the future of oncology clinical development

European Pharmaceutical Review

OCTOBER 26, 2023

Antibody-drug conjugates (ADCs), such as datopotamab deruxtecan (Dato-DXd) and trastuzumab deruxtecan, have demonstrated compelling evidence of efficacy in oncology across numerous diseases in recent months. What are the current trends in clinical development for oncology?

Chemotherapy

Moderna Announces Expansion of mRNA Research Across Respiratory, Oncology, Rare Disease Franchises

Pharmacy Times

SEPTEMBER 19, 2023

Moderna has advanced 6 programs into late-stage development, including for respiratory conditions, latent and other viruses, oncology, and rare diseases.

AbbVie and Tentarix collaborate on oncology and immunology treatments

Pharmafile

FEBRUARY 23, 2024

AbbVie and Tentarix Biotherapeutics have announced that they have entered a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology.

Advancing Healthcare Solutions: Harnessing Collaborative Business Models for Oncology

PharmExec

APRIL 18, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Generate:Biomedicines to collaborate on oncology cell therapies

Pharmaceutical Technology

NOVEMBER 2, 2023

Generate:Biomedicines has entered a strategic collaboration with Roswell Park to accelerate the development of new oncology therapies

Oncology in the NHS: Situations, challenges, and solutions

pharmaphorum

OCTOBER 4, 2023

Oncology in the NHS: Situations, challenges, and solutions Mike.Hammerton Wed, 04/10/2023 - 08:00 Bookmark this

Bayer and Aignostics to collaborate for AI oncology research

Pharmafile

MARCH 14, 2024

Bayer and Aignostics have announced that they have entered into a strategic collaboration for several artificial intelligence (AI)-powered approaches for precision oncology drug research and development.

$2 billion mRNA-based oncology therapy market anticipated by 2029

European Pharmaceutical Review

SEPTEMBER 1, 2023

The global mRNA-based oncology therapy market is expected to reach $2 billion by 2029, according to GlobalData. Global mRNA-based oncology therapy market At present, the pharmaceutical industry is still awaiting the first regulatory approval of an mRNA-based oncology therapy. percent share by 2029, the research has shown.

Immunization

Immunization Vaccines

Bayer pledges up to $1.5bn for Recursion oncology alliance

pharmaphorum

NOVEMBER 10, 2023

Bayer pledges up to $1.5bn for Recursion oncology alliance Phil.Taylor Fri, 10/11/2023 - 11:19 Bookmark this

Personalized Care, Collaboration Key to Navigating Ethics in Oncology Pharmacy

Empowering Oncology Pharmacists: Driving Innovation and Advancement Through Pharmacist-Led Research

Trending Sources

Navigating the Landscape of Cannabis Use in Oncology

Navigating the Oncology Specialty Patient Journey

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Teva enters into oncology biosimilar licensing agreement

A Call to Pharmacists in the Delivery of Oncology Care

What Does an Oncology Pharmacy Technician Do?

Enhancing Patient-Centric Oncology Care: The Crucial Role of Oncology Pharmacists in Treatment Decision-Making

Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

Top 5 Pharmacy Times Oncology Articles of 2023

STAT+: Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO

The Role of Oncology Pharmacists Is Evolving in Early-Stage Breast Cancer Treatment Optimization

CG Oncology is first biotech IPO of 2024, raising $380m

Pharmacy Focus: Oncology Edition - A Look Into Psychedelic Medicines for Oncology Care

Pharmacy Practice in Focus: Oncology Launches Peer-Review Process

Why Oncology Pharmacists Should Be at the Helm of Precision Medicine in Oncology

GSK immuno-oncology treatment achieves novel EU approval

Elements in precision oncology

Some States Allowing Donation and Redistribution of Oncology Drugs

Bladder cancer-focused CG Oncology files for IPO

Thyme Care unveils oncology practice partner network to scale value-based care

Merck, Johnson & Johnson Announce Acquisitions to Bolster Respective Oncology Pipelines

Approaching Ethical Dilemmas in Oncology Pharmacy

Expert: Mentorship in Oncology Pharmacy Has an Impact

Collaboration to develop novel AI-designed oncology therapy

AbbVie agrees $10 billion oncology acquisition

Oncology Pharmacists “Approve Every Regimen That Gets Built Into the Oncology EMR,” yet Pharma Often Overlooks Their Role

CG Oncology lines up $180m IPO and a $1bn valuation

Labcorp Announces Expansions to Oncology Portfolio

Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says

Inflation Reduction Act Could Cause Delay in New Oncology Treatments Under Medicare Negotiations

Cardiff Oncology doses first patient in colorectal cancer trial

Pharmacy Focus: Student Edition - Oncology Drug Development

Biofidelity’s ASPYRE: The future is bright for oncology

Antibody-drug conjugates: paving the future of oncology clinical development

Moderna Announces Expansion of mRNA Research Across Respiratory, Oncology, Rare Disease Franchises

AbbVie and Tentarix collaborate on oncology and immunology treatments

Advancing Healthcare Solutions: Harnessing Collaborative Business Models for Oncology

Generate:Biomedicines to collaborate on oncology cell therapies

Oncology in the NHS: Situations, challenges, and solutions

Bayer and Aignostics to collaborate for AI oncology research

$2 billion mRNA-based oncology therapy market anticipated by 2029

Bayer pledges up to $1.5bn for Recursion oncology alliance

Stay Connected